Mexico to hold trials for Chinese and American COVID-19 vaccines
August 12, 2020Research and Development COVID-19, Mexico, Mexico coronavirus
Mexico aims to conduct late stage trials for coronavirus vaccines designed by US and Chinese companies. This is in hope …
Moderna commits 100 million COVID-19 vaccine doses to the US
August 12, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, US, Vaccine, pharma
Moderna continues to rise to meet the demands of the pandemic, signing a new deal with the US Government to …
Pharmafile.com’s weekly COVID-19 news round-up
August 12, 2020Research and Development COVID-19, coronavirus, covid news
The coronavirus news this week once again focuses on vaccines, as AstraZeneca signed its first deal in China to produce …
Bayer scoops up women’s healthcare biotech KaNDy Therapeutics in potential $1bn+ deal
August 11, 2020Manufacturing and Production, Research and Development, Sales and Marketing Bayer, KaNDy Therapeutics, menopause, pharma
Bayer is set to acquire UK-based biotech KaNDy Therapeutics, assimilating the firm’s women’s healthcare development portfolio in a newly announced …
Roche’s entrolizumab disappoints at Phase 3 in moderately to severely active ulcerative colitis
August 11, 2020Manufacturing and Production, Research and Development Roche, etrolizumab, trial failure, ulcerative colitis
Roche has voiced its disappointment after its investigational therapy etrolizumab showed “mixed results” as a treatment for moderately to severely …
Gilead applies for FDA approval to treat coronavirus patients with remdesivir
August 11, 2020Manufacturing and Production COVID-19, Gilead, coronavirus
Gilead Sciences has asked the FDA to approve its drug remdesivir to treat COVID-19 patients. The drug would go under …
Arthritis drug Abatacept could be used to treat type 1 diabetes
August 11, 2020Manufacturing and Production diabetes, insulin, tye 1, type 2
People with type 1 diabetes could see their lives extended by the arthritis drug Abatacept, new study finds. Researchers at …
Russia becomes world’s first country to grant regulatory approval for a coronavirus vaccine
August 11, 2020Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus
President Putin has announced that Russia is the first country to grant regulatory approval for a COVID-19 vaccine. The final …
Dr Christine Wilkinson Blanc appointed as Chief Medical Officer at Nordic Nanovector
August 10, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Nordic Nanovector has announced that Dr Christine Wilkinson Blanc has been appointed as the Chief Medical Officer of the company.
Over 100 Americans have died after taking hydroxychloroquine in the first half of 2020
August 10, 2020Sales and Marketing COVID-19, chloroquine, coronavirus, hydroxychloroquine
More than 100 Americans have died after taking the drug hydroxychloroquine to treat or prevent coronavirus. This was found in …
Over a third of Americans say they won’t take a coronavirus vaccine
August 10, 2020Sales and Marketing COVID-19, coronavirus, vaccines
35% of Americans say they have no plans to take a COVID-19 vaccine, according to new polling. A new Gallup …
Novavax inks deal to deliver one billion COVID-19 vaccine doses in India and other regions
August 10, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, India, Novavax, Serum Institute of India Private Limited, Vaccine
Novavax is partnering up with the Serum Institute of India Private Limited (SIIPL) in a licensing deal to development and …
FDA approves opioid Olinvyk for patients with acute pain
August 10, 2020Sales and Marketing opioid crisis, opioids
The FDA has approved Olinvyk for the management of moderate to severe pain in adult patients when their pain is …
Genentech’s Evrysdi becomes first FDA-approved oral treatment for spinal muscular atrophy
August 10, 2020Sales and Marketing Evrysdi, FDA, Genentech, Roche, spinal muscular atrophy
Genentech’s Evrysdi (risdiplam) has secured FDA approval for the treatment of spinal muscular atrophy (SMA), making it the first oral therapy …
Early promise from Novavax’s vaccine candidate for COVID-19
August 7, 2020Medical Communications, Research and Development COVID-19, Novavax, Vaccine
New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used …
Researchers at the University of Oxford have said hydroxychloroquine could still be a viable COVID-19 treatment
August 7, 2020Medical Communications COVID, hydroxychloroquine
Researchers at the University of Oxford have said that hydroxychloroquine could be beneficial to COVID-19 patients, despite a general lack …
AstraZeneca seals manufacturing deal to deliver COVID-19 vaccine in China
August 7, 2020Manufacturing and Production, Medical Communications AstraZeneca, COVID-19, China, pharma
AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, …
Trump signs executive order to direct federal agencies to prioritise purchasing drugs made in the US
August 7, 2020Manufacturing and Production, Medical Communications, Sales and Marketing FDA, Peter Navarro, Trump, drug prices
US President Donald Trump has signed an executive order which will direct federal agencies to prioritise buying drugs and drug …
Top Ten most popular articles on Pharmafile.com this week
August 7, 2020Medical Communications COVID-19, Top 10 news, top 10
The top ten news stories this week are dominated by corporate scandals, with researchers finding that Coca-Cola paid an organisation …
AstraZeneca’s Fasenra has strong Phase 3 showing in severe eosinophilic asthma
August 6, 2020Research and Development AstraZeneca, Fasenra, asthma
AstraZeneca took the opportunity at the American Thoracic Society 2020 Virtual International Conference to unveil positive new Phase 3b data …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
